IMU Biosciences's $53M+: Decoding the Immune System at Scale
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Raising startup funding requires matching your stage, traction, and sector to the right investors. Our startup funding resources cover everything from first checks to growth rounds — with actionable guidance for founders navigating today's market.
Explore startup funding articles to sharpen your raise and find investors who fit your company.
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Bengaluru's FirstClub raised $55M Series B in June 2026, doubling its valuation to $255M by betting that quality — not just speed — wins quick commerce.
Stockholm AI startup Endra raised $50M Series A in June 2026 to automate design work for mechanical, electrical, and plumbing (MEP) consultants.
Aippy, built by NADA AI, raised tens of millions at a $250M valuation in June 2026 to build the first AI-native game community — Asia's answer to AI entertainment.
May's European funding headline was driven by a small set of mega-rounds in defense, space, quantum, and physical AI—not a broad-based recovery.
May's New York funding sample spans AI infrastructure, retail, wealth management, health, and SMB banking; the useful pattern is measurable workflow adoption.